Harry Kalms
Senior Investment Associate @ CPT Capital
London, United Kingdom
Harry Kalms is a seed investor at CPT Capital in London focused on Biotechnology and Commercial. Harry Kalms
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Harry Kalms invests in
Stages Harry Kalms invests in
Countries Harry Kalms invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Commercial 1 (50%)
- Life Science 1 (50%)
- 3D Technology 1 (50%)
- Food Processing 1 (50%)
Stage
- Seed 1 (50%)
- Series C 1 (50%)
Country
- Israel 1 (50%)
- United Kingdom 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Asterix Foods
|
Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel. | $4.2M / Seed / Oct 08, 2025 | |
ENOUGH
|
ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). Thisgives integrated fermentation production of Food, Fuel and Feed. | $43.9M / Series C / Aug 17, 2023 |
Co-Investors
About CPT Capital
CPT Capital is an investment firm that invests in visionary founders. Their mission is to drive the food and materials technology revolution by replacing animals in the supply chain.
CPT Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Debbie Jones
Chief Financial Officer
|
|||
|
Harry Kalms
Senior Investment Associate
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Harry Kalms invest in?
Harry Kalms invests primarily in Biotechnology, Commercial and Life Science startups, most often at Seed and Series C stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Harry Kalms last invest?
The most recent investment recorded for Harry Kalms closed in Oct 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
